LENZ Therapeutics, Inc. (LENZ) vs NRx Pharmaceuticals, Inc. (NRXP)

A side-by-side comparison of LENZ Therapeutics, Inc. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LENZ vs NRXP

growth of $100 · dividends reinvested · last 5y
LENZ -91.4% (-38.7%/yr)NRXP -97.9% (-54.0%/yr)LENZ compounded faster over this window
050100150Start $10020222023202420252026$9$2
LENZ NRXP

LENZ vs NRXP: by the numbers

  • •NRXP is the larger company ($127M vs $118M market cap).
  • •Both run net losses; LENZ's is the smaller (-586.74% vs -691.81% net margin).

Metrics side by side

Valuation

MetricLENZNRXP
P/S ratio5.4737.50
P/B ratio0.54N/A

Profitability

MetricLENZNRXP
Gross margin90.14%58.78%
Operating margin-477.46%-1324.41%
Net margin-586.74%-691.81%
ROE-57.47%N/A
ROIC-61.84%N/A

Growth (annualized)

MetricLENZNRXP
Total return CAGR (5Y)-35.49%-49.61%

Frequently asked

How have LENZ and NRXP total returns compared?
Over the past 5 years, LENZ delivered -35.49% and NRXP delivered -49.61% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.